SRPT : SAREPTA THERAPEUTICS INC stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-09-06 |
|---|---|---|---|---|
| 2024 | $129.7 | $124.88 | $135.62 | 0.6% |
| 2025 | $176.17 | $143.59 | $210.18 | 36.65% |
| 2026 | $180.91 | $166.35 | $201.93 | 40.32% |
| 2027 | $210.09 | $196.18 | $223.08 | 62.96% |
| 2028 | $200.54 | $196.26 | $203.67 | 55.55% |
| 2029 | $149.99 | $92.81 | $197.04 | 16.34% |
| 2030 | $81.07 | $69.95 | $89.82 | -37.12% |
| 2031 | $56.68 | $51.77 | $66.68 | -56.03% |
| 2032 | $53.03 | $50.14 | $61.43 | -58.87% |
| 2033 | $74.19 | $64.32 | $80.97 | -42.46% |
| 2034 | $87.97 | $82.0 | $92.25 | -31.76% |
The 34 Wall Street analysts offering SAREPTA THERAPEUTICS INC stock forecast in the last 6 months have average price target of
$182.03 with a high forecast of $235.0 and a low forecast of $128.0.
The average SAREPTA THERAPEUTICS INC stock forecast represents a 41.2%
increase from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast for 2024, 3 predictions are offered for each month of 2024 with average SAREPTA THERAPEUTICS INC stock
forecast of $129.7, a high forecast of $135.62, and a low forecast of $124.88.
The average SAREPTA THERAPEUTICS INC stock forecast 2024 represents a 0.6%
increase from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast for 2025, 12 predictions are offered for each month of 2025 with average SAREPTA THERAPEUTICS INC stock
forecast of $176.17, a high forecast of $210.18, and a low forecast of $143.59.
The average SAREPTA THERAPEUTICS INC stock forecast 2025 represents a 36.65%
increase from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast for 2027, 12 predictions are offered for each month of 2027 with average SAREPTA THERAPEUTICS INC stock
forecast of $210.09, a high forecast of $223.08, and a low forecast of $196.18.
The average SAREPTA THERAPEUTICS INC stock forecast 2027 represents a 62.96%
increase from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average SAREPTA THERAPEUTICS INC stock
forecast of $149.99, a high forecast of $197.04, and a low forecast of $92.81.
The average SAREPTA THERAPEUTICS INC stock forecast 2029 represents a 16.34%
increase from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast 2030, 12 predictions are offered for each month of 2030 with average SAREPTA THERAPEUTICS INC stock
forecast of $81.07, a high forecast of $89.82, and a low forecast of $69.95.
The average SAREPTA THERAPEUTICS INC stock forecast 2030 represents a -37.12%
decrease from the last price of $128.919998168945.
For SAREPTA THERAPEUTICS INC stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average SAREPTA THERAPEUTICS INC stock
forecast of $87.97, a high forecast of $92.25, and a low forecast of $82.0.
The average SAREPTA THERAPEUTICS INC stock forecast 2034 represents a -31.76%
decrease from the last price of $128.919998168945.
Please, see more forecasts below.
SRPT : SAREPTA THERAPEUTICS INC stock forecast by Wall Street Analysts
The average SAREPTA THERAPEUTICS INC stock forecast from last 6 month is $182.03, and this show a 7.37% increase in average from the prior price target of the each prediction. Also, this average forecast of $182.03 represents a 23.88% increase from the past average forecast of $146.94, 6 months ago from 31 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-06 | RBC Capital | $181.00 | $181.00 | Outperform |
| 2024-08-15 | RBC Capital | $181.00 | $181.0000 | Outperform |
| 2024-08-08 | Barclays | $226.00 | $203.0000 | Overweight |
| 2024-08-08 | Evercore ISI Group | $185.0000 | $179 | Outperform |
| 2024-08-08 | Piper Sandler | $205.00 | $200 | Overweight |
| 2024-08-08 | Cantor Fitzgerald | $167.0000 | $152 | Neutral |
| 2024-08-08 | Citigroup | $176.00 | $160.0000 | Neutral |
| 2024-08-08 | RBC Capital | $182.00 | $181 | Outperform |
| 2024-07-29 | RBC Capital | $182.0000 | Outperform | |
| 2024-07-01 | Piper Sandler | $205.0000 | $205 | Overweight |
| 2024-06-27 | Needham | $235.00 | $235 | Buy |
| 2024-06-26 | Citigroup | $172.00 | $176.0000 | Neutral |
| 2024-06-24 | Morgan Stanley | $165.00 | $200 | Overweight |
| 2024-06-24 | Evercore ISI Group | $139.0000 | $185 | In-Line |
| 2024-06-24 | Leerink Partners | $165.0000 | $230.0000 | Outperform |
| 2024-06-24 | BMO Capital | $170.00 | $200 | Outperform |
| 2024-06-21 | Piper Sandler | $157.00 | $157 | Overweight |
| 2024-06-21 | Morgan Stanley | $165.0000 | $165 | Overweight |
| 2024-06-21 | Cantor Fitzgerald | $128.00 | $128.00 | Neutral |
| 2024-06-21 | RBC Capital | $142.00 | $182.0000 | Sector Perform |
| 2024-06-21 | Barclays | $185.0000 | $226.0000 | Overweight |
| 2024-06-21 | Baird | $170.0000 | $200 | Outperform |
| 2024-06-21 | B of A Securities | $166.0000 | $213 | Buy |
| 2024-06-21 | Needham | $166.00 | $235.0000 | Buy |
| 2024-06-18 | BMO Capital | $170.00 | $170 | Outperform |
| 2024-06-14 | BMO Capital | $170.00 | $170 | Outperform |
| 2024-05-31 | Piper Sandler | $157.0000 | Overweight | |
| 2024-05-28 | RBC Capital | $157.0000 | $142.0000 | Sector Perform |
| 2024-05-20 | Needham | $166.0000 | Buy | |
| 2024-05-17 | Mizuho | $145.00 | $179 | Buy |
| 2024-05-14 | Oppenheimer | $180 | Outperform | |
| 2024-05-03 | JP Morgan | $177.0000 | $175.0000 | Overweight |
| 2024-05-02 | Needham | $166.0000 | Buy | |
| 2024-05-02 | Cantor Fitzgerald | $128.0000 | Neutral | |
| 2024-03-01 | UBS | $164.0000 | $167 | Buy |
| 2024-02-29 | Needham | $169.00 | $166.0000 | Buy |
| 2024-02-29 | Barclays | $141.00 | $185.0000 | Overweight |
| 2024-02-29 | Citigroup | $160.0000 | $172 | Buy |
| 2024-02-29 | RBC Capital | $151.00 | $157.0000 | Outperform |
| 2024-02-29 | Cantor Fitzgerald | $128.0000 | Neutral | |
| 2024-02-20 | Wedbush | $224.0000 | Outperform | |
| 2024-02-20 | Evercore ISI Group | $108.0000 | $138 | In-Line |
| 2024-02-16 | Needham | $140.00 | $169.0000 | Buy |
| 2024-02-15 | Cantor Fitzgerald | $128.0000 | Neutral | |
| 2024-02-14 | Cantor Fitzgerald | $128.0000 | Neutral | |
| 2024-02-14 | Mizuho | $130.0000 | $145.0000 | Buy |
| 2024-01-31 | BMO Capital | $170.0000 | Outperform | |
| 2024-01-30 | Wedbush | $224.0000 | Outperform | |
| 2024-01-29 | Needham | $140.0000 | Buy | |
| 2024-01-25 | RBC Capital | $155.0000 | $151.0000 | Outperform |
| 2024-01-10 | Needham | $93.00 | $140 | Buy |
| 2024-01-09 | Wedbush | $224.0000 | Outperform | |
| 2023-12-13 | Citigroup | $113.0000 | Buy | |
| 2023-12-12 | Deutsche Bank | $109.0000 | Buy | |
| 2023-11-21 | Wedbush | $224.0000 | Outperform | |
| 2023-11-21 | RBC Capital | $148.0000 | Outperform | |
| 2023-11-02 | Needham | $82.00 | $93.0000 | Buy |
| 2023-11-02 | Cantor Fitzgerald | $40.00 | $80.0000 | Neutral |
| 2023-11-02 | Barclays | $193.0000 | $141 | Overweight |
| 2023-10-31 | Needham | $185.00 | $82.0000 | Buy |
| 2023-10-31 | Morgan Stanley | $183.00 | $146.0000 | Overweight |
| 2023-10-31 | Cantor Fitzgerald | $166.00 | $40.0000 | Neutral |
| 2023-10-31 | RBC Capital | $217.0000 | $148.0000 | Outperform |
| 2023-10-31 | JP Morgan | $211.0000 | $115.0000 | Overweight |
| 2023-09-26 | Mizuho | $160.0000 | Buy |
SAREPTA THERAPEUTICS INC stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-09-09 | $125.22 | -2.87% |
| 2024-09-10 | $124.52 | -0.56% |
| 2024-09-11 | $127.99 | 2.79% |
| 2024-09-12 | $133.84 | 4.56% |
| 2024-09-13 | $132.76 | -0.80% |
SRPT : Long term SAREPTA THERAPEUTICS INC stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $124.88 , for 2025 Sep. is $200.29 , for 2028 Sep. is $201.42 , for 2029 Sep. is $118.78 , for 2033 Sep. is $78.41 , and for 2034 Sep. is $90.76.
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Oct. | $124.88 | -3.13% |
| 2024 Nov. | $128.59 | 2.97% |
| 2024 Dec. | $135.62 | 5.47% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $143.59 | 5.88% |
| 2025 Feb. | $147.04 | 2.40% |
| 2025 Mar. | $152.73 | 3.87% |
| 2025 Apr. | $157.87 | 3.37% |
| 2025 May. | $163.95 | 3.85% |
| 2025 Jun. | $167.03 | 1.88% |
| 2025 Jul. | $172.78 | 3.44% |
| 2025 Aug. | $184.62 | 6.85% |
| 2025 Sep. | $200.29 | 8.49% |
| 2025 Oct. | $210.18 | 4.94% |
| 2025 Nov. | $209.90 | -0.14% |
| 2025 Dec. | $204.06 | -2.78% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $195.73 | -4.08% |
| 2026 Feb. | $187.92 | -3.99% |
| 2026 Mar. | $179.75 | -4.35% |
| 2026 Apr. | $173.51 | -3.47% |
| 2026 May. | $169.02 | -2.59% |
| 2026 Jun. | $166.53 | -1.47% |
| 2026 Jul. | $166.35 | -0.11% |
| 2026 Aug. | $170.48 | 2.48% |
| 2026 Sep. | $177.30 | 4.00% |
| 2026 Oct. | $186.70 | 5.30% |
| 2026 Nov. | $195.63 | 4.78% |
| 2026 Dec. | $201.93 | 3.22% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $206.41 | 2.22% |
| 2027 Feb. | $212.02 | 2.72% |
| 2027 Mar. | $218.53 | 3.07% |
| 2027 Apr. | $222.99 | 2.04% |
| 2027 May. | $223.08 | 0.04% |
| 2027 Jun. | $220.14 | -1.32% |
| 2027 Jul. | $215.38 | -2.16% |
| 2027 Aug. | $208.42 | -3.23% |
| 2027 Sep. | $202.88 | -2.66% |
| 2027 Oct. | $198.31 | -2.25% |
| 2027 Nov. | $196.71 | -0.81% |
| 2027 Dec. | $196.18 | -0.27% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $196.26 | 0.04% |
| 2028 Feb. | $196.87 | 0.31% |
| 2028 Mar. | $198.23 | 0.69% |
| 2028 Apr. | $200.42 | 1.10% |
| 2028 May. | $202.69 | 1.13% |
| 2028 Jun. | $203.67 | 0.49% |
| 2028 Jul. | $203.18 | -0.24% |
| 2028 Aug. | $202.37 | -0.40% |
| 2028 Sep. | $201.42 | -0.47% |
| 2028 Oct. | $201.15 | -0.13% |
| 2028 Nov. | $200.75 | -0.20% |
| 2028 Dec. | $199.47 | -0.64% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $197.04 | -1.22% |
| 2029 Feb. | $193.11 | -2.00% |
| 2029 Mar. | $187.56 | -2.87% |
| 2029 Apr. | $180.86 | -3.57% |
| 2029 May. | $173.28 | -4.19% |
| 2029 Jun. | $164.44 | -5.10% |
| 2029 Jul. | $152.36 | -7.34% |
| 2029 Aug. | $135.74 | -10.91% |
| 2029 Sep. | $118.78 | -12.50% |
| 2029 Oct. | $106.06 | -10.71% |
| 2029 Nov. | $97.83 | -7.76% |
| 2029 Dec. | $92.81 | -5.13% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $89.82 | -3.22% |
| 2030 Feb. | $87.86 | -2.18% |
| 2030 Mar. | $86.29 | -1.78% |
| 2030 Apr. | $84.94 | -1.57% |
| 2030 May. | $83.65 | -1.51% |
| 2030 Jun. | $82.40 | -1.49% |
| 2030 Jul. | $81.15 | -1.51% |
| 2030 Aug. | $79.80 | -1.67% |
| 2030 Sep. | $78.07 | -2.16% |
| 2030 Oct. | $75.80 | -2.92% |
| 2030 Nov. | $73.04 | -3.64% |
| 2030 Dec. | $69.95 | -4.23% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $66.68 | -4.67% |
| 2031 Feb. | $63.51 | -4.75% |
| 2031 Mar. | $60.74 | -4.37% |
| 2031 Apr. | $58.48 | -3.71% |
| 2031 May. | $56.75 | -2.97% |
| 2031 Jun. | $55.46 | -2.27% |
| 2031 Jul. | $54.53 | -1.68% |
| 2031 Aug. | $53.84 | -1.27% |
| 2031 Sep. | $53.29 | -1.01% |
| 2031 Oct. | $52.80 | -0.92% |
| 2031 Nov. | $52.30 | -0.95% |
| 2031 Dec. | $51.77 | -1.01% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $51.25 | -1.01% |
| 2032 Feb. | $50.77 | -0.93% |
| 2032 Mar. | $50.38 | -0.78% |
| 2032 Apr. | $50.14 | -0.47% |
| 2032 May. | $50.14 | -0.01% |
| 2032 Jun. | $50.42 | 0.56% |
| 2032 Jul. | $51.19 | 1.54% |
| 2032 Aug. | $52.41 | 2.38% |
| 2032 Sep. | $53.96 | 2.95% |
| 2032 Oct. | $55.82 | 3.46% |
| 2032 Nov. | $58.40 | 4.61% |
| 2032 Dec. | $61.43 | 5.19% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $64.32 | 4.71% |
| 2033 Feb. | $66.64 | 3.60% |
| 2033 Mar. | $68.32 | 2.52% |
| 2033 Apr. | $70.45 | 3.13% |
| 2033 May. | $73.24 | 3.95% |
| 2033 Jun. | $74.99 | 2.40% |
| 2033 Jul. | $76.10 | 1.48% |
| 2033 Aug. | $77.26 | 1.52% |
| 2033 Sep. | $78.41 | 1.49% |
| 2033 Oct. | $79.37 | 1.23% |
| 2033 Nov. | $80.17 | 1.00% |
| 2033 Dec. | $80.97 | 1.00% |
SRPT : SAREPTA THERAPEUTICS INC stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $82.00 | 1.27% |
| 2034 Feb. | $83.39 | 1.70% |
| 2034 Mar. | $85.14 | 2.10% |
| 2034 Apr. | $87.03 | 2.22% |
| 2034 May. | $88.85 | 2.09% |
| 2034 Jun. | $90.51 | 1.86% |
| 2034 Jul. | $91.82 | 1.45% |
| 2034 Aug. | $92.25 | 0.47% |
| 2034 Sep. | $90.76 | -1.61% |
Frequently Asked Questions about SAREPTA THERAPEUTICS INC stock forecast
Is SAREPTA THERAPEUTICS INC a good long term stock?
From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock cannot be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2024 Oct. is $124.883066370255 From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock can be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2025 Sep. is $200.287295985914 From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock can be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2028 Sep. is $201.419625089303 From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock cannot be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2029 Sep. is $118.77743166769 From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock cannot be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2033 Sep. is $78.4095986335579 From SAREPTA THERAPEUTICS INC stock forecast , SAREPTA THERAPEUTICS INC (SRPT) stock cannot be a good investment choice. According to AIPickup, the SAREPTA THERAPEUTICS INC stock price forecast for 2034 Sep. is $90.762312713145
Is SAREPTA THERAPEUTICS INC stock overvalued?
SAREPTA THERAPEUTICS INC (SRPT) stock is expected to go UP . Therefore, AIPickup would say that SAREPTA THERAPEUTICS INC (SRPT) stock is NOT overvalued.
Will SAREPTA THERAPEUTICS INC stock price go up?
Yes. The SAREPTA THERAPEUTICS INC stock price forecast for 2025 Sep. is $200.287295985914
Is SAREPTA THERAPEUTICS INC stock a good buy now?
Since closing price on 2024-09-06 is $128.919998168945 and forecast for 2025 Sep. is $200.29, SAREPTA THERAPEUTICS INC stock is a good 1 year investment.
14 Days Historical Data for SAREPTA THERAPEUTICS INC stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| SRPT stock price for 2024-08-19 | $137.28 | $133.07 | $133.07 | $137.48 |
| SRPT stock price for 2024-08-20 | $140.49 | $139.72 | $138.40 | $142.95 |
| SRPT stock price for 2024-08-21 | $143.45 | $141.25 | $141.09 | $143.52 |
| SRPT stock price for 2024-08-22 | $141.43 | $144.09 | $140.09 | $144.22 |
| SRPT stock price for 2024-08-23 | $140.56 | $142.01 | $140.41 | $143.49 |
| SRPT stock price for 2024-08-26 | $140.35 | $141.01 | $139.57 | $141.72 |
| SRPT stock price for 2024-08-27 | $140.65 | $140.01 | $138.14 | $140.89 |
| SRPT stock price for 2024-08-28 | $138.91 | $140.37 | $138.14 | $140.97 |
| SRPT stock price for 2024-08-29 | $137.25 | $139.10 | $136.80 | $140.10 |
| SRPT stock price for 2024-08-30 | $135.78 | $138.17 | $134.53 | $138.71 |
| SRPT stock price for 2024-09-03 | $135.10 | $135.45 | $133.97 | $138.71 |
| SRPT stock price for 2024-09-04 | $134.79 | $133.96 | $132.72 | $135.38 |
| SRPT stock price for 2024-09-05 | $133.77 | $134.84 | $133.22 | $135.27 |
| SRPT stock price for 2024-09-06 | $128.92 | $134.00 | $126.82 | $134.55 |